Rick Ascroft is the Chief Executive Officer North America of Sun Pharmaceutical Industries, Inc., the U.S. subsidiary of Sun Pharmaceutical Industries Limited.

Rick is a seasoned biopharmaceutical executive with more than three decades experience spanning commercial operations, market access, clinical development, and corporate affairs across the U.S. and global markets. Most recently, he served as Senior Vice President and Business Unit Head of U.S. Plasma-Derived Therapies at Takeda Pharmaceuticals.

Rick earned his J.D. from Indian University Robert H. McKinney School of Law and his Bachelor of Science in Pharmacy at Butler University.